The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Business Trip
00:00
Navigating Challenges and Opportunities in the Psychedelic Industry
The chapter explores the evolution of startups like MAPS and Compass Pathways in the psychedelic industry, discussing the balance between public benefit and private profit, challenges in fundraising, therapy protocols, and commercial interests. It delves into the differences between severe and mild PTSD populations in MDMA therapy, the impact of FDA restrictions, and the viability of recycling revenue into non-profits. The conversation also analyzes investor sentiment, institutional preferences, Oregon's role in setting trends, and the challenges of federal illegality in the industry.
Transcript
Play full episode
